Truist Financial
IMGN

Truist Financial’s Immunogen Inc IMGN Stock Holding History

Truist Financial’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-186,910
Closed -$1.39M – 2892
2021
Q4 		$1.39M Sell
186,910
-24,233
-11% -$151K ﹤0.01% 1468
2021
Q3 		$1.2M Buy
211,143
+175
+0.1% +$1.01K ﹤0.01% 1507
2021
Q2 		$1.39M Buy
210,968
+19,375
+10% +$135K ﹤0.01% 1461
2021
Q1 		$1.55M Sell
191,593
-28,583
-13% -$233K ﹤0.01% 1361
2020
Q4 		$1.42M Buy
220,176
+29,448
+15% +$172K ﹤0.01% 1324
2020
Q3 		$686K Buy
190,728
+73,750
+63% +$298K ﹤0.01% 1554
2020
Q2 		$538K Buy
116,978
+25,793
+28% +$110K ﹤0.01% 1580
2020
Q1 		$311K Sell
91,185
-1,149
-1% -$5.02K ﹤0.01% 1835
2019
Q4 		$472K Buy
+92,334
New +$313K ﹤0.01% 1903

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Truist Financial's IMGN Position: Q1 2022 in Review

Truist Financial sold out of Immunogen Inc (IMGN) in Q1 2022, closing a stake of 186,910 shares — an estimated $1.39M sold.

Truist Financial first reported a position in IMGN in Q4 2019 and held it in 9 quarters. The position peaked at $1.55M in Q1 2021. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2022.

  • Truist Financial reported no remaining Immunogen Inc position as of Q1 2022 after selling out during the quarter.
  • Truist Financial sold 186,910 Immunogen Inc shares in Q1 2022, an estimated $1.39M.
  • Truist Financial first reported a position in Immunogen Inc in Q4 2019 and held it in 9 quarters.
  • Truist Financial's Immunogen Inc position peaked at $1.55M in Q1 2021.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.